NCT00321555 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- LMB-2 Infusion: 40 micro-g/Kg will be infused in 50 ml of 0.9% Sodium chloride (NaCl) and 0.2% albumin via over 30 minutes every other day for 3 doses. Patients may receive up to six treatment cycles every 4 weeks. Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin: LMB-2 Infusion: 40 micro-g/Kg will be infused in 50 ml of 0.9% Sodium Chloride (NaCl) and 0.2% albumin via over 30 minutes every other day for 3 doses. Patients may receive up to six treatment cycles every 4 weeks.
- id
- FG000
- title
- LMB-2 to Treat Hairy Cell Leukemia
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Developed antibodies
- reasons
- group Id
- FG000
- num Subjects
- 3
- type
- Switched to alternative treatment
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Disease progression on study
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 15
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 9
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 6
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- LMB-2 Infusion: 40 micro-g/Kg will be infused in 50 ml of 0.9% Sodium chloride (NaCl) and 0.2% albumin via over 30 minutes every other day for 3 doses. Patients may receive up to six treatment cycles every 4 weeks. Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin: LMB-2 Infusion: 40 micro-g/Kg will be infused in 50 ml of 0.9% Sodium Chloride (NaCl) and 0.2% albumin via over 30 minutes every other day for 3 doses. Patients may receive up to six treatment cycles every 4 weeks.
- id
- FG000
- title
- LMB-2 to Treat Hairy Cell Leukemia
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Developed antibodies
- reasons
- group Id
- FG000
- num Subjects
- 3
- type
- Switched to alternative treatment
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Disease progression on study
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 15
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 9
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 6
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle